A Prospective, Multicenter, Non-interventional Registry Study Evaluating the Clinical Application of PEG-rhG-CSF During Chemotherapy in Patients With Malignant Solid Tumors in Sichuan
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 800
- 试验地点
- 1
- 主要终点
- Dosage of PEG-rhG-CSF in chemotherapy
研究概览
简要总结
Prospective, multicenter, non-interventional registration studies were used in this project . Eight hundreds patients with solid tumors who met the inclusion criteria in six hospitals in Sichuan Province, Sichuan Province, were selected from the first chemotherapy cycle using PEG-rhG-CSF (can be any chemotherapy cycle of the patient), and each subsequent chemotherapy cycle was recorded. The use of PEG-rhG-CSF and related patient outcomes until the end of chemotherapy. Analyze the clinical practice of using PEG-rhG-CSF in the real world.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age ≥ 18 years old;
- •Diagnosed as a malignant solid tumor by histology and cytology, requiring chemotherapy patients;
- •The first use of PEG-rhG-CSF during the chemotherapy cycle (not limited to the first chemotherapy cycle, can be any chemotherapy cycle of the patient);
- •Subjects volunteered to participate in this clinical trial and signed informed consent.
排除标准
- •PEG-rhG-CSF was used in the current chemotherapy cycle;
- •Have received hematopoietic stem cell transplantation or bone marrow transplantation;
- •Other drug clinical trials are currently underway.
结局指标
主要结局
Dosage of PEG-rhG-CSF in chemotherapy
时间窗: 1 YEAR
Administration time of PEG-rhG-CSF in chemotherapy
时间窗: 1 YEAR
dosing frequency of PEG-rhG-CSF in chemotherapy
时间窗: 1 YEAR
次要结局
未报告次要终点
研究者
DaiYuan Ma
Director of Cancer Center Affiliation: Affiliated Hospital of North Sichuan Medical College
Affiliated Hospital of North Sichuan Medical College